Santhera Pharmaceuticals Holding AG (SANN.SW) Income Statement 2006 - 2024

Santhera Pharmaceuticals Holding AG

Swiss Stock Exchange:SANN.SW

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

Switzerland

Market Cap

USD 229.75 M

Share Price

USD 17.86

Avg Daily Volume

35,045

Change (1 day)

2.55%

Change (1 year)

71.06%

Change (YTD)

16.85%

Santhera Pharmaceuticals Holding AG Income Statement 2014 - 2024

This table shows the Income Statement for Santhera Pharmaceuticals Holding AG going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.